Development of FRESH (Fast Rescue Employing Self-Helper virus) - a rapid, generalizable method to rescue infectious virus from noninfectious genomic material
FRESH(使用自助病毒快速救援)的开发 - 一种从非感染性基因组材料中拯救感染性病毒的快速、通用方法
基本信息
- 批准号:10089402
- 负责人:
- 金额:$ 29.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-27 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
While tools to manipulate viral nucleic acids have improved rapidly, methods to rescue infectious virus from
genomic material that is not infectious have not. Methods for virus rescue are available for increasing numbers
of virus species but must be individually developed and optimized for each different group of related viruses—a
process that is time-consuming and costly. Therefore, there is a need to develop a generalizable synthetic
genomics technology to facilitate rapid rescue of broad range of viruses at a reduced research cost to speed the
development of genetic tools for novel, emerging, or understudied viruses. Here, we propose to develop FRESH
(Fast Rescue Employing Self-Helper virus), a rescue strategy for viruses with noninfectious genomes and test
its applicability for rescue of DNA and RNA viruses in prokaryotic and eukaryotic hosts. To boot infectivity of the
genomic material with FRESH, a helper virus of the same virus species supplies trans-acting factors. In order to
inhibit packaging of the helper virus, its genome is differentially targeted for CRISPR-Cas digestion. Sequence
variation between the helper virus genome and the rescued genome, due to existing natural inter-strain variation
or engineered mutations, confer immunity to the CRISPR guide RNAs. We have used FRESH to rescue African
swine fever virus, which has a large DNA genome that is not infectious and no reported rescue methodology. To
test the effectiveness of FRESH in a bacterial host, we propose to rescue P68, a virus of Staphylococcus, and
inhibit the helper virus strain with CRISPR-Cas9 digestion. We will also develop FRESH with a Cas13 effector
in mammalian cells to rescue human respiratory syncytial virus (RSV), as a model for negative-sense single-
stranded RNA viruses. For each virus, we will determine the most effective guide RNAs, which will be used to
inhibit the wild-type self-helper virus. Since we have already developed synthetic genomics tools for P68 and
RSV, we will engineer the genomes to include a fluorescent reporter and to modify the sgRNA target regions,
thus generating a CRISPR-immune reporter genome to be rescued. If these experiments are successful,
additional work will be performed to define a straightforward FRESH rescue system that could be rapidly
employed for previously undescribed viruses. Combined, FRESH and synthetic genomics can rapidly introduce
sophisticated reverse genetics to virus species with noninfectious genomes allowing researchers to begin
developing effective viral countermeasures in less time.
虽然操纵病毒核酸的工具迅速改善,但从
没有传染性的基因组材料没有。病毒救援方法可用于增加数量
病毒物种,但必须针对每个不同的相关病毒进行单独开发和优化 - A
耗时且昂贵的过程。因此,有必要开发可推广的合成
基因组技术以降低的研究成本促进促进广泛病毒的快速营救,以加快
开发用于新颖,新兴或理解病毒的遗传工具。在这里,我们建议开发新鲜
(快速救援使用自助病毒),这是一种非感染基因组病毒的救援策略
它适用于原核生物和真核宿主中DNA和RNA病毒的拯救。引导感染
带有新鲜的基因组材料,是同一病毒物种的辅助病毒提供跨作用因子。为了
抑制辅助病毒的包装,其基因组针对CRISPR-CAS消化的目标不同。顺序
由于现有的自然应变变异,辅助病毒基因组和救出的基因组之间的变化
或工程突变,赋予CRISPR指南RNA的免疫力。我们已经用新鲜来营救非洲人
猪发烧病毒,具有大型DNA基因组,该基因组没有传染性,没有报道的救援方法。到
在细菌宿主中测试新鲜的有效性,我们建议营救P68,即葡萄球菌病毒和
用CRISPR-CAS9消化抑制辅助病毒菌株。我们还将使用CAS13效应器开发新鲜
在哺乳动物细胞中拯救人呼吸道合胞病毒(RSV),作为负敏感的单个模型
滞留的RNA病毒。对于每种病毒,我们将确定最有效的指南RNA,将用于
抑制野生型自助病毒。由于我们已经为p68开发了合成基因组学工具
RSV,我们将设计基因组以包括荧光报告基因并修改SGRNA目标区域,
从而产生CRISPR-Mumune报告基因组将被救出。如果这些实验成功,
将进行额外的工作来定义一个直接的新鲜救援系统,这可能是迅速的
用于以前未描述的病毒。结合,新鲜和合成的基因组学可以迅速引入
软化的反向遗传学对具有非感染基因组的病毒物种,使研究人员可以开始
在更少的时间内开发有效的病毒对策。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Sanjay Vashee的其他基金
Synthetic Genomics to Improve a Phage-Based Diagnostic for Multi-Drug Resistant Bacteria
合成基因组学改进基于噬菌体的多重耐药细菌诊断
- 批准号:98085759808575
- 财政年份:2019
- 资助金额:$ 29.25万$ 29.25万
- 项目类别:
A Synthetic Human Cytomegalovirus Vaccine Platform
合成人巨细胞病毒疫苗平台
- 批准号:86875828687582
- 财政年份:2013
- 资助金额:$ 29.25万$ 29.25万
- 项目类别:
Combinatory Genomic Assembly to Assess HSV-1 Phenotypes
用于评估 HSV-1 表型的组合基因组组装
- 批准号:86236728623672
- 财政年份:2013
- 资助金额:$ 29.25万$ 29.25万
- 项目类别:
Combinatory Genomic Assembly to Assess HSV-1 Phenotypes
用于评估 HSV-1 表型的组合基因组组装
- 批准号:87796128779612
- 财政年份:2013
- 资助金额:$ 29.25万$ 29.25万
- 项目类别:
A Synthetic Human Cytomegalovirus Vaccine Platform
合成人巨细胞病毒疫苗平台
- 批准号:85894358589435
- 财政年份:2013
- 资助金额:$ 29.25万$ 29.25万
- 项目类别:
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:BB/Y006224/1BB/Y006224/1
- 财政年份:2024
- 资助金额:$ 29.25万$ 29.25万
- 项目类别:Research GrantResearch Grant
Understanding differences in host responses to African swine fever virus
了解宿主对非洲猪瘟病毒反应的差异
- 批准号:BB/Z514457/1BB/Z514457/1
- 财政年份:2024
- 资助金额:$ 29.25万$ 29.25万
- 项目类别:FellowshipFellowship
2023 International Society for Vaccines (ISV) Annual Congress, October 22-25, Lausanne, Switzerland
2023 年国际疫苗协会 (ISV) 年会,10 月 22 日至 25 日,瑞士洛桑
- 批准号:1075484010754840
- 财政年份:2023
- 资助金额:$ 29.25万$ 29.25万
- 项目类别:
Sulfated Poly-Amido-Saccharide (sulPAS) Biomaterials as Anticoagulants
作为抗凝剂的硫酸化聚酰胺糖 (sulPAS) 生物材料
- 批准号:1064952210649522
- 财政年份:2022
- 资助金额:$ 29.25万$ 29.25万
- 项目类别:
Exploiting novel African swine fever virus virulence factors and a porcine macrophage cell line to develop a live attenuated vaccine
利用新型非洲猪瘟病毒毒力因子和猪巨噬细胞系开发减毒活疫苗
- 批准号:BB/V007947/1BB/V007947/1
- 财政年份:2021
- 资助金额:$ 29.25万$ 29.25万
- 项目类别:Research GrantResearch Grant